Skip to content

Clinical trials

Completed Phase 2 Alzheimer Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 2 Status: Completed Clear all

334 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20024
20035
200412
200512
200618
200715
200820
200928
201010
201129
201220
20136
201411
201518
201614
201716
201821
201917
202016
20216
202211
20236
20248
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed334

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer13
Eli Lilly and Company11
Avid Radiopharmaceuticals9
GlaxoSmithKline8
University of Wisconsin, Madison6
AbbVie (prior sponsor, Abbott)5
Boehringer Ingelheim5
Genentech, Inc.5
Novartis4
Photozig, Inc.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease334
Cognitive Dysfunction67
Dementia59
Neurodegenerative Diseases16
Central Nervous System Diseases14
Memory Disorders12
Brain Diseases9
Tauopathies9
Mental Disorders8
Psychomotor Agitation8

Trials

Showing 1 to 25 of 334. Each trial links to its page on Pharma Observatory.

234 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.